发明名称 Modified biotin-binding protein, fusion proteins thereof and applications
摘要 The disclosure provides modified biotin-binding proteins which can be expressed in soluble form in high yield in bacteria. Also provided are fusion proteins comprising the modified biotin-binding protein and an antigen. The disclosure further provides non-hemolytic variants of alpha-hemolysin from S. aureus and fusion protein comprising non-hemolytic variant of alpha-hemolysin and a biotin-binding domains. Immunogenic compositions comprising the proteins are also disclosed and use of such immunogenic compositions for inducing an immune response or for vaccinating a subject are also disclosed.
申请公布号 US9499593(B2) 申请公布日期 2016.11.22
申请号 US201214116492 申请日期 2012.05.11
申请人 Children's Medical Center Corporation 发明人 Malley Richard;Lu Yingjie;Zhang Fan
分类号 A61K39/00;A61K39/02;C07K14/31;A61K47/48 主分类号 A61K39/00
代理机构 Nixon Peabody LLP 代理人 Nixon Peabody LLP
主权项 1. A vaccine composition comprising a soluble biotin-binding protein consisting essentially of an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 1, wherein the biotin-binding protein has a higher solubility than the biotin-binding protein of SEQ ID NO: 4.
地址 Boston MA US